ASCEND BY NTHRYS
Research Abroad Products

Molecular Pharmacology Project Topics

Browse all focused areas across all project categories under this field.

Showing 169–180 of 200 project topics
Renin-Angiotensin-Aldosterone System Modulation Predictive Analytics
A proprietary platform predicting patient response to ACE inhibitors, ARBs, and aldosterone antagonists using ACE2, AT1 receptor expression, and genetic polymorphism data. Generates revenue through pharmaceutical partnerships, precision medicine licensing, and direct-to-patient stratification services.
Cardiovascular Molecular Pharmacology Analytics Click to view more details →
Thrombotic Risk Stratification Software for Anticoagulant Drug Selection
A clinical decision support tool integrating molecular markers (thrombin generation, platelet reactivity, tissue factor pathway inhibitor) with genetic data to recommend personalized anticoagulation strategies. Recurring SaaS revenue of $50K-200K per institution plus per-patient licensing fees.
Cardiovascular Molecular Pharmacology Analytics Click to view more details →
AI-Powered Tumor Mutation Profiling and Drug Matching Platform
SaaS platform that sequences tumor DNA, identifies actionable mutations, and algorithmically matches patients to precision oncology drugs in real-time. Generates recurring revenue through laboratory partnerships, pharmaceutical companies, and hospital networks seeking companion diagnostic solutions.
Oncology Molecular Pharmacology Drug Platforms Click to view more details →
Kinase Inhibitor Virtual Screening and Optimization Toolkit
Computational drug discovery platform using molecular docking and machine learning to rapidly identify and optimize lead kinase inhibitor compounds against oncology targets. Monetizes through pharma R&D licensing, hit-to-lead stage partnerships, and subscription-based access to proprietary kinase databases.
Oncology Molecular Pharmacology Drug Platforms Click to view more details →
Real-Time Cancer Cell Line Drug Sensitivity Testing Service
High-throughput screening service that tests patient-derived or commercial cancer cell lines against panels of oncology drugs to predict treatment response. Delivers value through clinical decision support fees, pharmaceutical efficacy validation contracts, and biomarker discovery partnerships.
Oncology Molecular Pharmacology Drug Platforms Click to view more details →
Antibody-Drug Conjugate Design and Validation Platform
Software-as-a-service tool for rational ADC design, linker optimization, and payload selection using computational chemistry and structure-activity relationship prediction. Creates revenue through drug development milestone payments, licensed IP, and partnerships with monoclonal antibody manufacturers.
Oncology Molecular Pharmacology Drug Platforms Click to view more details →
Immunotherapy Biomarker Stratification and Response Prediction Engine
Cloud-based analytics platform integrating genomic, transcriptomic, and proteomic data to predict checkpoint inhibitor response and patient stratification in oncology trials. Generates B2B revenue through clinical trial enrollment optimization, pharmaceutical development support, and companion diagnostic licensing.
Oncology Molecular Pharmacology Drug Platforms Click to view more details →
Protein-Protein Interaction Modulator Discovery and Library Platform
Proprietary platform combining phage display, computational modeling, and synthetic chemistry to design and screen protein-protein interaction modulators for oncology targets. Monetizes through hit discovery partnerships, platform licensing to pharmaceutical companies, and royalty arrangements on clinical candidates.
Oncology Molecular Pharmacology Drug Platforms Click to view more details →
Patient Pharmacogenomics and Drug Toxicity Risk Profiling Tool
Clinical decision support software that analyzes patient genetic profiles to predict chemotherapy metabolism, optimal dosing, and adverse event risk for oncology drugs. Revenue model includes per-patient testing fees, integration with hospital EMR systems, and insurance reimbursement from precision medicine protocols.
Oncology Molecular Pharmacology Drug Platforms Click to view more details →
Small Molecule CDK and Cell Cycle Inhibitor Virtual Library and Screening
Commercial chemistry platform providing pre-validated CDK inhibitor compounds, synthetic routes, and structure-activity relationship datasets for rapid oncology drug development. Drives revenue through chemical library licensing, custom synthesis services, and lead optimization partnerships with biotech firms.
Oncology Molecular Pharmacology Drug Platforms Click to view more details →
Epigenetic Drug Target Identification and HDAC Modulator Design Suite
Integrated software suite for identifying dysregulated epigenetic pathways in cancers and designing histone deacetylase inhibitors and chromatin remodeling drugs. Monetizes through epigenetics-focused drug discovery partnerships, academic licensing, and pharmaceutical preclinical validation contracts.
Oncology Molecular Pharmacology Drug Platforms Click to view more details →
Multi-Target Oncology Drug Combination Optimization and Clinical Trial Matching
AI-driven platform that models synergistic drug combinations, predicts efficacy and toxicity interactions, and matches patients to optimal combination therapy regimens in real-time. Generates revenue through clinical trial patient recruitment optimization, pharmaceutical development accelerators, and hospital oncology decision support subscriptions.
Oncology Molecular Pharmacology Drug Platforms Click to view more details →